Wednesday, June 10, 2026

biotech · Breast Cancer · Pleural carcinosis · SANA

Sana Biotechnology

News and analysis for Sana Biotechnology on NovaPharmaNews — regulatory, clinical, and market coverage.

188 E Blaine St, Suite 400, Seattle, Washington 98102, US HQ
2018 Founded
265 Employees
Public company Type
SANA · NYSE Ticker
Company details
Status
Public
HQ
188 E Blaine St, Suite 400, Seattle, Washington 98102, US
Founded
2018
Employees
265
Programs
19
Drugs
21
Patents
136
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Sana Biotechnology — regulatory, clinical, and market coverage.

News and analysis for Sana Biotechnology on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Sana Biotechnology yet.

Back to company overview →